Discover
QNTM
Quantum BioPharma Ltd.
3.36
2 x 2.61
2 x 4.12
bid
ask
-
0.26
7.18%
2 @ 04:00 PM
3.42 +0.06 (1.79%)
| Ytd | -53.97% | |
| 1y | -82.61% |
3.21
day range
3.64
2.07
52 week range
31.91
| Open | 3.62 | Prev Close | 3.62 | Low | 3.21 | High | 3.64 | Mkt Cap | 21.50M |
| Vol | 216.35K | Avg Vol | 372.70K | EPS | -7.73 | P/E | N/A | Forward P/E | -0.41 |
| Beta | 0.76 | Short Ratio | 0.09 | Inst. Own | 16.65% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-18 | 50-d Avg | 5.02 | 200-d Avg | 7.40 | 1yr Est | 169.00 |
| Income Statement | |||
| Operating Expenses | 2.97M | ||
| Research and Development Expense | 626.09K | ||
| Selling, General and Administrative Expense | 1.32M | ||
| Operating Income | -2.97M | ||
| Interest Expense | 45.18K | ||
| Net Income | -13.56M | ||
| Net Income Common Stock | -13.56M | ||
| Net Income Common Stock (USD) | -9.83M | ||
| Consolidated Income | -13.75M | ||
| Net Income to Non-Controlling Interests | -193.26K | ||
| Earnings per Basic Share | -3.06 | ||
| Earnings per Basic Share (USD) | -2.22 | ||
| Earnings per Diluted Share | -3.06 | ||
| Earning Before Interest & Taxes (EBIT) | -13.52M | ||
| Earning Before Interest & Taxes (USD) | -9.79M | ||
| Weighted Average Shares | 4.49M | ||
| Weighted Average Shares Diluted | 4.49M | ||
| Balance Sheet | |||
| Cash and Equivalents | 4.34M | ||
| Cash and Equivalents (USD) | 3.15M | ||
| Investments | 5.69M | ||
| Investments Current | 5.69M | ||
| Trade and Non-Trade Receivables | 208.52K | ||
| Current Assets | 10.37M | ||
| Property, Plant & Equipment Net | 147.54K | ||
| Total Assets | 14.93M | ||
| Debt Current | 870.06K | ||
| Total Debt | 870.06K | ||
| Current Liabilities | 16.35M | ||
| Total Liabilities | 16.35M | ||
| Accumulated Retained Earnings (Deficit) | -211.85M | ||
| Accumulated Other Comprehensive Income | 214.53K | ||
| Shareholders Equity | 595.23K | ||
| Shareholders Equity (USD) | 431.32K | ||
| Assets Non-Current | 4.56M | ||
| Total Debt (USD) | 630.48K | ||
| Goodwill and Intangible Assets | 4.41M | ||
| Inventory | 51.47K | ||
| Trade and Non-Trade Payables | 3.59M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 127.44K | ||
| Net Cash Flow from Financing | 7.00M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 2.44M | ||
| Issuance (Purchase) of Equity Shares | 5.29M | ||
| Issuance (Repayment) of Debt Securities | 1.71M | ||
| Net Cash Flow from Investing | -2.89M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | -2.89M | ||
| Net Cash Flow from Operations | -1.67M | ||
| Share Based Compensation | 892.06K | ||